| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/31/2011 | CN102171209A Inhibitors of IAP |
| 08/31/2011 | CN102171208A Isatin derivatives for use as in vivo imaging agents |
| 08/31/2011 | CN102171206A Diazepine and diazocane compounds as MC4 agonists |
| 08/31/2011 | CN102171205A Pyrazinone modulator of corticotropin-releasing factor receptor activity |
| 08/31/2011 | CN102171204A 8-substituted isoquinoline derivative and use thereof |
| 08/31/2011 | CN102171202A Pyridine and pyrimidine based compounds as WNT signaling pathway inhibitors for the treatment of cancer |
| 08/31/2011 | CN102171196A Oxazole derivatives useful as inhibitors of FAAH |
| 08/31/2011 | CN102171193A Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 08/31/2011 | CN102171192A Indazole compound |
| 08/31/2011 | CN102171191A Indazole derivative |
| 08/31/2011 | CN102171189A Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 08/31/2011 | CN102171188A Tripyridyl carboxamide orexin receptor antagonists |
| 08/31/2011 | CN102171187A PSMA-binding agents and uses thereof |
| 08/31/2011 | CN102171185A Methionine analogs and methods of using same |
| 08/31/2011 | CN102171184A Organosulfur compounds, a method of making organosulfur compounds and their use for inhibiting the growth of tumour cells |
| 08/31/2011 | CN102171183A Organic compounds |
| 08/31/2011 | CN102170910A Novel use application of sugar chain-recognizing receptor |
| 08/31/2011 | CN102170908A Delivery of a CD40 agonist to a tumor draining lymph node of a subject |
| 08/31/2011 | CN102170888A Paeoniflorin preparations and uses thereof for fat reduction |
| 08/31/2011 | CN102170887A Modulation of TOLL-like receptor 7 expression by antisense oligonucleotides |
| 08/31/2011 | CN102170886A Treatment of vaginal atrophy in women with tumor pathology risk |
| 08/31/2011 | CN102170885A Pharmaceutical composition for oral administration |
| 08/31/2011 | CN102170884A Oral formulation |
| 08/31/2011 | CN102170883A Compounds useful as inhibitors of protein kinases |
| 08/31/2011 | CN102170882A Compositions and methods of treating amyloid disease |
| 08/31/2011 | CN102170881A 3, 3', 4, 4' -tetrahydroxy-2, 2' -bipyridine-n, n' -dioxides for the treatment of renal cell carcinoma |
| 08/31/2011 | CN102170880A Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
| 08/31/2011 | CN102170879A Modified release formulation and methods of use |
| 08/31/2011 | CN102170878A Controlled release pharmaceutical composition |
| 08/31/2011 | CN102170877A Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers |
| 08/31/2011 | CN102170876A Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient |
| 08/31/2011 | CN102170875A Chewing gum containing low dose amounts of water soluble vitamins |
| 08/31/2011 | CN102170874A Compositions and methods for treating psychiatric disorders |
| 08/31/2011 | CN102170873A Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 08/31/2011 | CN102170872A Method of modulating membrane potential of a cell |
| 08/31/2011 | CN102170870A An extended release pharmaceutical composition of entacapone or salts thereof |
| 08/31/2011 | CN102170869A Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
| 08/31/2011 | CN102170865A Eye drop with difluprednate for macular edema treatment |
| 08/31/2011 | CN102170864A Respiratory disease treatment |
| 08/31/2011 | CN102170863A Mucomimetic compositions and uses therefore |
| 08/31/2011 | CN102170862A Modified release emulsions for application to skin or vaginal mucosa |
| 08/31/2011 | CN102170798A Composition for promoting control of total and LDL cholesterol and/or weight loss and/or thermogenesis |
| 08/31/2011 | CN102170786A Pharmaceutical compositions and methods for producing low impurity concentrations of the same |
| 08/31/2011 | CN102170784A Treatment of hepatitis C infection with metalloporphyrins |
| 08/31/2011 | CN102170783A HDAC4, HDAC5, HDAC6, HDAC7, and HIF1alpha modulation of retinal cell survival |
| 08/31/2011 | CN102170782A Novel method |
| 08/31/2011 | CN102168119A Method for preparing diaporthein B and application of diaporthein B to preparation of antitumor medicaments |
| 08/31/2011 | CN102167812A Pegylated cyclopamine analog and preparation method as well as application thereof |
| 08/31/2011 | CN102167720A Betulonic acid derivant for restraining differentiation of osteoclast, preparation method thereof and application thereof |
| 08/31/2011 | CN102167718A 16-imidazole substitute-3amine substitute-5 alpha androstane derivatives and preparation method and application thereof |
| 08/31/2011 | CN102167697A Novel structure, synthesis method and application of hypoxia injury resistant compounds |
| 08/31/2011 | CN102167695A Benzimidazole-carbonyl-pyridine-amino-ehtyl-propionate hemihyrate and its use |
| 08/31/2011 | CN102167690A Icariin aglucone derivative and preparation method and application thereof |
| 08/31/2011 | CN102167687A Novel compound, anti-tumor agent, pharmaceutical, food and cosmetic |
| 08/31/2011 | CN102167685A 4-(2'-n-butyl-4,5-disubstituted-2,4'-bis-imidazole-3'-methyl) benzoic acid derivative |
| 08/31/2011 | CN102166376A Ophthalmic medicine-carried amnion and preparation method thereof |
| 08/31/2011 | CN102166364A Inhibitor of calcium-independent phospholipase A2 used for treating oophoroma |
| 08/31/2011 | CN102166363A Application of miR-21 to preparing medicines for promoting healing of skin injury |
| 08/31/2011 | CN102166360A Ibuprofen intravenously administrable preparation and preparation method thereof |
| 08/31/2011 | CN102166359A Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 08/31/2011 | CN102166358A Use of inhibitors of jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166339A Uyghur galenical preparation for hair growing and nourishing and preparation method thereof |
| 08/31/2011 | CN102166337A Ginger and inula flower composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
| 08/31/2011 | CN102166336A Composition of loguat leaves and ginger as well as preparation method and application thereof to preparing toxicity reducing and efficacy enhancing medicines for radiotherapy and chemotherapy of cancers |
| 08/31/2011 | CN102166335A Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
| 08/31/2011 | CN102166334A Externally-applied medicament for treating infantile eczema and senile pruritus and preparation method thereof |
| 08/31/2011 | CN102166331A Medicament for treating hemorrhoids and preparation method thereof |
| 08/31/2011 | CN102166324A Medicament for treating skin infection diseases |
| 08/31/2011 | CN102166323A Medicine for curing burn and preparation method thereof |
| 08/31/2011 | CN102166316A Medicament for treating aphthous stomatitis |
| 08/31/2011 | CN102166307A Medicine for curing trichomadesis |
| 08/31/2011 | CN102166292A Externally-applied Chinese medicinal preparation for losing weight and preparation method thereof |
| 08/31/2011 | CN102166285A Umbilical plaster for treating allergic skin itching and psoriasis and preparation method thereof |
| 08/31/2011 | CN102166283A Externally-applied treatment fluid for treating burns and scalds and preparation method thereof |
| 08/31/2011 | CN102166263A Compound preparation for treating cervical spondylotic myelopathy and preparation method thereof |
| 08/31/2011 | CN102166251A Solid biological medicament for treating stomach cancer, large intestine cancer and alimentary canal diseases |
| 08/31/2011 | CN102166250A Liquid biological medicament for treating esophagus cancer, cardiac cancer and diseases of digestive tract |
| 08/31/2011 | CN102166240A Chinese medicinal composition for treating rectum and anus disease and method for preparing same |
| 08/31/2011 | CN102166239A Product for preventing and/or treating diabetes |
| 08/31/2011 | CN102166227A Pharmaceutical composition with function of enhancing immunity |
| 08/31/2011 | CN102166224A Antibiotic mate for treating colibacillosis and preparation method thereof |
| 08/31/2011 | CN102166223A Composition for treating streptococcus suis and method for preparing composition |
| 08/31/2011 | CN102166220A Bacille calmette-guerin (BCG) immunosuppressant, and preparation method and application thereof |
| 08/31/2011 | CN102166219A Nasal administration preparation and application thereof |
| 08/31/2011 | CN102166218A Method and composition for treatment of neoplasms |
| 08/31/2011 | CN102166217A Use of Bordetella pertussis CpG-ODNs (CpG oligodeoxynucleotides) as medicine for preventing and treating asthma |
| 08/31/2011 | CN102166216A Lactulose oral solution and quality control method thereof |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN102166214A Medical application of aminothiazole type MyD88 specific inhibitor |
| 08/31/2011 | CN102166213A Composition using levalbuterol and ipratropium bromide as active ingredients |
| 08/31/2011 | CN102166212A Method for making benidipine hydrochloride quickly dissolved from tablets |
| 08/31/2011 | CN102166211A Use of derivatives of 1-deoxynojiri mycin containing 1,2,3-triazoles as alpha-glucosidase inhibitors |
| 08/31/2011 | CN102166210A Use of derivatives of 1-deoxynojiri mycin as alpha-glucosidase inhibitors |
| 08/31/2011 | CN102166209A Compound pantoprazole sodium pharmaceutical composition solid preparation |
| 08/31/2011 | CN102166208A Lisinopril and hydrochlorothiazide pharmaceutical composition liposome solid preparation |
| 08/31/2011 | CN102166207A Application of artemether in preparation of anopheline mosquito immune system inhibitor |
| 08/31/2011 | CN102166206A Liquid oseltamivir phosphate composition |
| 08/31/2011 | CN102166205A New medical application of paeonol and derivatives thereof |
| 08/31/2011 | CN102166204A Pharmaceutical composition for preventing and/or treating bone loss |